Pediatric Hemophagocytic Lymphohistiocytosis: Formation of an Interdisciplinary HLH Working Group at a Single Institution

被引:3
|
作者
Watts, Shelley [1 ]
Diaz, Maranda [2 ,3 ]
Teller, Christa [2 ,3 ]
Hamby, Tyler [1 ,4 ]
Guirola, Ricardo [5 ]
Perez, Maria [5 ]
Eames, Gretchen [2 ,3 ]
Howrey, Richard [2 ,3 ]
Rios, Ana [6 ]
Trinkman, Heidi [2 ,3 ]
Ray, Anish [2 ,3 ,7 ]
机构
[1] Univ North Texas Hlth Sci Ctr, Texas Coll Osteopath Med, Ft Worth, TX USA
[2] Cook Childrens Hlth Care Syst, Dept Pediat Hematol, Ft Worth, TX USA
[3] Cook Childrens Hlth Care Syst, Dept Oncol, Ft Worth, TX USA
[4] Cook Childrens Hlth Care Syst, Res Operat, Ft Worth, TX USA
[5] Cook Childrens Hlth Care Syst, Pediat Rheumatol, Ft Worth, TX USA
[6] Cook Childrens Hlth Care Syst, Pediat Infect Dis, Ft Worth, TX USA
[7] 1500 Cooper St,5th floor, Ft Worth, TX 76104 USA
关键词
hemophagocytic lymphohistiocytosis (HLH); pediatric; fever of unknown origin (FUO); UNKNOWN ORIGIN; PROLONGED FEVER; CHILDREN; EXPERIENCE;
D O I
10.1097/MPH.0000000000002602
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fever of unknown origin is a common presentation in children with an extensive differential diagnosis that encompasses multiple specialties. From a hematologic standpoint, the differential includes hyperinflammatory syndrome, such as hemophagocytic lymphohistiocytosis (HLH), among others. Due to the rarity of HLH and nonspecific symptoms at initial presentation, specialists are often consulted later in the disease progression, which complicates disease evaluation further. Cook Children's Medical Center (CCMC) has recently developed a multidisciplinary histiocytic disorder group that is often consulted on cases presenting with fever of unknown origin to increase awareness and potentially not miss new HLH cases. In this study, we examine the clinical presentation and workup of 13 patients consulted by the HLH work group at a single institution and describe the clinical course of 2 patients diagnosed with HLH. The goal of this project was to describe the formation of a disease-specific team and the development of a stepwise diagnostic approach to HLH. A review of the current diagnostic criteria for HLH may be warranted given findings of markers such as soluble IL2 receptor and ferritin as nonspecific and spanning multiple disciplines including rheumatology, infectious disease, and hematology/oncology.
引用
收藏
页码:E328 / E333
页数:6
相关论文
共 50 条
  • [41] Hemophagocytic lymphohistiocytosis: A series of five clinical cases in adult patients at a single institution with a review of the literature
    Thomas, David
    Shah, Nihar
    Patel, Hiren
    Pandya, Tapan
    Gauchan, Dron
    Maroules, Michael
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2015, 7 (09) : 415 - 420
  • [42] Scrub Typhus-Associated Hemophagocytic Lymphohistiocytosis: Not a Rare Entity in Pediatric Age Group
    Basu, Ankika
    Chowdhoury, Satyabrata Roy
    Sarkar, Mihir
    Khemka, Arpita
    Mondal, Rakesh
    Datta, Kalpana
    Mondal, Kalyanbrata
    JOURNAL OF TROPICAL PEDIATRICS, 2021, 67 (01)
  • [43] HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ASSOCIATED WITH HEMATOLOGIC MALIGNANCIES IN PEDIATRIC AGE GROUP IS AN INDICATIVE OF POOR PROGNOSIS
    Unal, S.
    Cetin, M.
    Gumruk, E.
    Gurgey, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 479 - 479
  • [44] Genetic characterization of pediatric primary hemophagocytic lymphohistiocytosis in China: a single-center study
    Liping Zhang
    Zhigang Li
    Wei Liu
    Honghao Ma
    Tianyou Wang
    Rui Zhang
    Annals of Hematology, 2019, 98 : 2303 - 2310
  • [45] Genetic characterization of pediatric primary hemophagocytic lymphohistiocytosis in China: a single-center study
    Zhang, Liping
    Li, Zhigang
    Liu, Wei
    Ma, Honghao
    Wang, Tianyou
    Zhang, Rui
    ANNALS OF HEMATOLOGY, 2019, 98 (10) : 2303 - 2310
  • [46] SAFETY OF EMAPALUMAB IN PEDIATRIC PATIENTS WITH PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH): FINDINGS FROM THE PRIMARY ANALYSIS OF THE PIVOTAL PHASE 2/3 STUDY
    Locatelli, Franco
    Jordan, Michael
    Allen, Carl
    Cesaro, Simone
    Rizzari, Carmelo
    Rao, Anupama
    Degar, Barbara
    Garrington, Timothy
    Sevilla, Julian
    Putti, Maria Caterina
    Fagioli, Franca
    Ahlmann, Martina
    Dapena Diaz, Jose-Luis
    Henry, Michael
    De Benedetti, Fabrizio
    Grom, Alexei
    Jacqmin, Philippe
    Ballabio, Maria
    de Min, Cristina
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [47] Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China
    Shuai, Xiao
    Xu, Juan
    Zhong, Xushu
    Li, Yan
    Tang, Wenjiao
    Zhu, Huanling
    Niu, Ting
    Wu, Yu
    Jia, Yongqian
    Cui, Xu
    Pan, Ling
    Chang, Hong
    Gong, Yuping
    Xiang, Bing
    Huang, Jie
    Li, Jianjun
    He, Chuan
    Chen, Xinchuan
    Xie, Liping
    Ma, Hongbing
    Ji, Jie
    Dai, Yang
    Liu, Zhigang
    Liu, Ting
    BLOOD, 2016, 128 (22)
  • [48] Characteristics and Outcomes of Malignancy-Associated Hemophagocytic Lymphohistiocytosis (M-HLH) in Adult Patients: A Single-Center Experience
    Assi, Rita
    Boddu, Prajwal
    Kadia, Tapan
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Jabbour, Elias
    Takahashi, Koichi
    Konopleva, Marina
    Abou Zahr, Abdallah
    DiNardo, Courtney
    Borthakur, Gautam
    Jain, Nitin
    Pemmaraju, Naveen
    Ning, Jing
    Pierce, Sherry
    Wierda, William
    Cortes, Jorge
    Kantarjian, Hagop
    Daver, Naval
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10): : S18 - S19
  • [49] Hemophagocytic Lymphohistiocytosis (HLH) Associated ALK-Positive Anaplastic Large Cell Lymphoma (ALCL) with Leukemic Involvement and Central Nervous System (CNS) Disease: A Single Institution Case Series
    Amos, L.
    Wood, N.
    Hetherington, M.
    Hays, A.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S213 - S214
  • [50] A single dose of anti-mouse IFNg reduces key clinical and laboratory features of hemophagocytic lymphohistiocytosis (HLH) in a mouse model
    Buatois, V.
    Chatel, L.
    Cons, L.
    Pinschewer, D.
    Baker, M.
    De Min, C.
    Kosco-Vilbois, M. H.
    Ferlin, W. G.
    IMMUNOLOGY, 2011, 135 : 118 - 118